Skip to main content
Clinical Trials/NCT03342040
NCT03342040
Completed
N/A

Randomized Clinical Trial: Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair

GEM Hospital & Research Center1 site in 1 country90 target enrollmentOctober 15, 2017
ConditionsVentral Hernia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Ventral Hernia
Sponsor
GEM Hospital & Research Center
Enrollment
90
Locations
1
Primary Endpoint
Post operative cumulative analgesic requirement
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The current study aims to determine if transverse abdominis plane block using local anesthetic agents (bupivacaine 0.25% + Ropivacaine 0.20%) decreases the post operative pain and helps in early mobilization or discharge from hospital in patients undergoing laparoscopic ventral hernia repair.

Detailed Description

Patients meeting inclusion criteria would be randomised after admission. Those patients in experimental arm shall receive the TAP block under USG guidance while those in control arm do not receive any block. Surgery shall be proceeded in the usual manner in all the patients and assessment for pain starts in the immediate post operative or recovery room after the patient is completely conscious. The total amount of analgesic required by the patient is measured. Pain assessment is done using the visual analog scale (VAS) at regular intervals until follow up review.

Registry
clinicaltrials.gov
Start Date
October 15, 2017
End Date
February 1, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
GEM Hospital & Research Center
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients undergoing laparoscopic ventral hernia repair during the study period

Exclusion Criteria

  • Age \<15 or greater than 75 years
  • Obstructed , recurrent or strangulated hernia
  • Lap assisted open hernia repair
  • Patients undergoing component separation
  • Parastomal hernia, spigelian hernia, lumbar hernia
  • Patients with Chronic kidney disease, bronchial asthma
  • Patients allergic to bupivacaine or NSAIDs
  • Not willing to participate

Outcomes

Primary Outcomes

Post operative cumulative analgesic requirement

Time Frame: 24 hours after surgery

The amount of analgesic required by the patient during hospital stay

Secondary Outcomes

  • Post-operative hospital stay(7 days from primary surgery)

Study Sites (1)

Loading locations...

Similar Trials